Treatment-resistant depression (TRD) affects many individuals who have not found relief through traditional antidepressant therapies. At Lighthouse Psychiatry, we explore innovative treatments to help our patients find effective solutions. One such treatment is Spravato (esketamine), a form of ketamine therapy.
Understanding Spravato-Ketamine
Spravato is a nasal spray containing esketamine, a derivative of ketamine, which has shown promise in treating TRD. Unlike traditional antidepressants, which can take weeks to become effective, Spravato can provide rapid relief from depressive symptoms.
How Does Spravato-Ketamine Work?
Spravato targets the NMDA receptors in the brain, which are involved in mood regulation. By modulating these receptors, Spravato can help alleviate depressive symptoms quickly, often within hours of administration. This makes it a valuable option for those who have not responded to other treatments.
Who is a Candidate for Spravato-Ketamine Treatment?
Spravato is typically considered for individuals with TRD who have tried multiple antidepressants without success. It is also being explored for its potential benefits in other conditions, such as ADHD. Ketamine therapy in AZ, including Spravato, is administered under the supervision of a qualified healthcare provider to ensure safety and effectiveness.
The Process of Spravato-Ketamine Treatment
The treatment involves a series of sessions where Spravato is administered in a controlled medical setting. Patients are monitored during and after each session to assess their response and manage any potential side effects.
Ketamine for ADHD
Research is ongoing into the use of ketamine for ADHD. While traditional ADHD treatments focus on stimulant medications, ketamine’s unique mechanism of action offers a new avenue for those who may not respond to conventional therapies.
Safety and Efficacy
Spravato has been approved by the FDA for TRD, and studies have demonstrated its efficacy and safety when used appropriately. However, it is essential to undergo this treatment under the guidance of a psychiatric medication management provider to ensure the best outcomes and minimize risks.
Explore this Innovative Treatment Option
Spravato-ketamine treatment offers hope for individuals with treatment-resistant depression and potentially for those with ADHD. At Lighthouse Psychiatry, we provide ketamine therapy in AZ to help patients explore this innovative treatment option. If you are struggling with TRD or are interested in ketamine ADHD treatment, contact us to learn more about how Spravato-ketamine may benefit you.
